The following is a summary of the Symrise AG (SYIEF) Q3 2024 Earnings Call Transcript:

Financial Performance:

• Symrise AG reported organic sales growth of 11.1% in the first 9 months of the fiscal year, reaching EUR 3.8 billion.

• Despite slight negative real pricing effects, organic growth was bolstered by a 2.3% impact from hyperinflation-related pricing adjustments.

• The company has revised its full year sales growth expectation to around 7%, excluding hyperinflation effects.

Business Progress:

• The Taste, Nutrition & Health segment showed robust growth, with a 10.4% increase organically year-to-date, and an accelerated volume performance in Q3.

• The Scent & Care division achieved a 12.2% organic growth in the first 9 months, with all divisions experiencing double-digit volume increases despite some price declines.

• Symrise is focusing on innovation through an internal ecosystem combining various technologies, targeting sustainable solutions for customers.

Opportunities:

• Significant growth contributions from hyperinflation adjustments indicate strong resilience against economic fluctuations.

• The continuing expansion of the company's international operations, including recent tours in Asia, Latin and North America, as well as upcoming visits to Madagascar and Dubai, amplify its global reach and operational strength.

Risks:

• Hyperinflation-related effects will present a negative impact on organic growth in Q4 due to the substantial devaluation of the Argentinian peso, affecting the overall annual growth figures.

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.